Loading...

PODCAST

Research To Practice | Oncology Videos

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

science medicine

All Episodes

13:58

HER2-Positive Gynecologic Cancers — Microlearning...

Research To Practice | Oncology Videos ·

2026/10/07

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics: Case: A woman in her mid 60s with Stage II uterine carcinosarcoma treated with surgery followed by paclitaxel/carboplatin, whole-pelvic radiation and vaginal cuff brachytherapy — Dr Angeles Alvarez Secord (0:00) Case: A woman in her mid 50s with ovarian cancer and a genomic instability score of 50, folate receptor alpha 90%, HER2 IHC 2+, and BRCA1/2

en-us

47:06

Diffuse Large B-Cell Lymphoma — An Interview with Dr...

Research To Practice | Oncology Videos ·

2026/10/05

Featuring an interview with Dr L Elizabeth Budde, including the following topics: Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00) Management of BsAb-induced cytokine release syndrome and other toxicities (7:35) Use of BsAbs in the front-line treatment of diffuse large B-cell lymphoma (DLBCL); key findings from the Phase II MorningSun study (17:30) Case: A man in his mid 50s with relapsed/refractory (R/R) DLBCL receives mosunetuzumab

en-us

27:35

Diffuse Large B-Cell Lymphoma — An Interview with Dr...

Research To Practice | Oncology Videos ·

2026/10/05

Featuring a slide presentation and related discussion from Dr L Elizabeth Budde, including the following topics: Overview of approved and investigational CD20 x CD3 bispecific antibodies (BsAbs) in non-Hodgkin lymphoma; key findings from Phase II studies evaluating glofitamab and epcoritamab in relapsed/refractory (R/R) diffuse large B-cell lymphoma (0:00) Bringing BsAbs into earlier-line settings; key findings from Phase III studies (7:49) Key findings from the Phase III EPCORE DLBCL-1 and

en-us

50:34

Lung Cancer — Proceedings from a Symposium Held in...

Research To Practice | Oncology Videos ·

2026/10/04

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) EGFR Mutations (2:23) HER2 Alterations (22:40) Available and Investigational Immunotherapies (32:14) Small Cell Lung Cancer (40:48) CME information and select publications

en-us

52:24

Prostate Cancer with PTEN Deficiency — An Interview...

Research To Practice | Oncology Videos ·

2026/10/03

Featuring an interview with Dr Neeraj Agarwal, including the following topics: Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00) Approaches to monitoring for disease progression in patients who are PTEN deficient; prognostic significance and implications for testing (7:13) Potential usage of capivasertib as second-line therapy for metastatic androgen pathway modulation-naïve/-sensitive (APMN/S) prostate cancer (15:15) Managing treatment-related adverse events

en-us

23:44

Prostate Cancer with PTEN Deficiency — An Interview...

Research To Practice | Oncology Videos ·

2026/10/02

Featuring a slide presentation and related discussion from Dr Neeraj Agarwal, including the following topics: Therapeutic targets of systemic therapy in prostate cancer (0:00) Prevalence of genomic alterations in prostate cancer including PTEN deficiency; prognostic and predictive value (3:52) Optimal timing of and approach to PTEN assessment; pathophysiology surrounding PTEN loss (9:29) Comparison of ipatasertib and capivasertib; key findings from Phase III IPATential150 and

en-us

50:22

Diffuse Large B-Cell Lymphoma — Proceedings from a...

Research To Practice | Oncology Videos ·

2026/10/02

Featuring perspectives from Dr Ann LaCasce and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) First-Line Treatment (1:33) Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy (20:36) CME information and select publications

en-us

23:26

HER2-Positive Gynecologic Cancers — Microlearning...

Research To Practice | Oncology Videos ·

2026/10/01

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics: Case: A woman in her mid 60s with metastatic serous endometrial carcinoma that is HER2 IHC 3+ who received first-line carboplatin/paclitaxel/trastuzumab and second-line trastuzumab deruxtecan — Ursula Matulonis, MD (0:00) Commentary: Role of HER2-directed therapy in the maintenance setting for patients with HER2-positive disease — Professor Jonathan A

en-us

51:22

Ovarian and Endometrial Cancer — Proceedings from a...

Research To Practice | Oncology Videos ·

2026/09/30

Featuring perspectives from Dr Shannon N Westin and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) Ovarian Cancer (2:22) Endometrial Cancer (37:48) CME information and select publications

en-us

58:01

For Oncology Nurses: Non-Small Cell Lung Cancer with...

Research To Practice | Oncology Videos ·

2026/09/30

Featuring an interview with Dr Alexander E Drilon, including the following topics: Overview of targetable biomarkers in lung cancer (0:00) Biomarker testing for genomic alterations in lung cancer (5:24) Overview of ROS1 alterations in lung cancer (13:44) Efficacy data with ROS1 inhibitors for lung cancer (17:02) Safety data with ROS1 inhibitors for lung cancer (21:15) Case: A woman in her early 50s with a history of non-small cell lung cancer (NSCLC) undergoes biomarker testing to reveal a ROS1

en-us

48:25

Glucocorticoid Receptor Antagonists for Ovarian...

Research To Practice | Oncology Videos ·

2026/09/29

Featuring an interview with Professor Nicoletta Colombo, including the following topics: Mechanistic effects and rationale underlying the use of relacorilant/nab paclitaxel (0:00) Rationale underlying the study design of the Phase II BELLA trial and avenues for future exploration (8:31) Definition of platinum ineligibility; importance of platinum-containing chemotherapy for patients with ovarian cancer (14:02) Findings from a Phase II trial and the subsequent confirmatory Phase III ROSELLA study

en-us

36:27

Glucocorticoid Receptor Antagonists for Ovarian...

Research To Practice | Oncology Videos ·

2026/09/29

Featuring a slide presentation and related discussion from Professor Nicoletta Colombo, including the following topics: Rationale for targeting the glucocorticoid receptor; relacorilant mechanism of action (0:00) Key efficacy and safety findings from a Phase II study of relacorilant/nab paclitaxel for platinum-ineligible ovarian cancer (3:09) Key findings from the Phase III ROSELLA study (7:06) Case: A woman in her early 50s with FIGO Stage IVB platinum-ineligible high-grade serous carcinoma

en-us

50:22

Gastroesophageal Cancers — Proceedings from a...

Research To Practice | Oncology Videos ·

2026/09/28

Featuring perspectives from Dr Samuel J Klempner and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) First-Line Treatment of Metastatic Gastroesophageal Cancer (1:48) Management of HER2-Positive Gastroesophageal Cancer (25:11) Neoadjuvant Therapy for Gastroesophageal Cancer (45:13) Note to listeners: Subsequent to the recording of this symposium, the FDA approved zanidatamab in combination with chemotherapy with and without tislelizumab for

en-us

54:25

Chronic Lymphocytic Leukemia — Proceedings from a...

Research To Practice | Oncology Videos ·

2026/09/28

Featuring perspectives from Dr Farrukh T Awan and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) First-Line Therapy (2:48) Relapsed/Refractory Disease (39:30) CME information and select publications

en-us

01:28:21

Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia...

Research To Practice | Oncology Videos ·

2026/09/25

Featuring perspectives from Dr Brad S Kahl, Dr Jeff Sharman and Dr Tanya Siddiqi, including the following topics: Introduction (0:00) Trials in Progress (1:12) Chronic Lymphocytic Leukemia (7:09) Diffuse Large B-Cell Lymphoma (32:35) Mantle Cell Lymphoma (58:25) Follicular Lymphoma (1:14:49) CME information and select publications

en-us

09:31

HER2-Positive Gynecologic Cancers — Microlearning...

Research To Practice | Oncology Videos ·

2026/09/24

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topic: Case: A woman in her late 50s with a BRCA1 germline mutation and platinum- and PARP inhibitor-resistant metastatic ovarian cancer with low folate receptor alpha level and HER2 IHC 1+ — Professor Jonathan A Ledermann CME information and select publications

en-us

23:11

Antibody-Drug Conjugates for Multiple Myeloma — An...

Research To Practice | Oncology Videos ·

2026/09/23

Featuring a slide presentation and related discussion from Dr Douglas W Sborov, including the following topics: Overview of the treatment landscape for early relapsed multiple myeloma (MM) (0:00) Belantamab mafodotin (belamaf) mechanism of action and Phase II DREAMM-2 study of belamaf monotherapy in heavily pretreated MM (6:20) DREAMM-7 and DREAMM-8 Phase III trials of belamaf combination strategies in patients with MM in the second- and later-line settings (9:20) Monitoring for and management of

en-us

49:41

Antibody-Drug Conjugates for Multiple Myeloma — An...

Research To Practice | Oncology Videos ·

2026/09/23

Featuring an interview with Dr Douglas W Sborov, including the following topics: DREAMM-2 trial outcomes and clinical development of antibody-drug conjugates for multiple myeloma (MM); mechanism of action of belantamab mafodotin (belamaf) and predictors of response to treatment (0:00) Perspectives on findings from the Phase III DREAMM-7 trial of belamaf combined with bortezomib/dexamethasone for relapsed/refractory MM (4:26) Progression-free survival estimates with current quadruplet induction and

en-us

23:55

Metastatic Triple-Negative Breast Cancer — 5-Minute...

Research To Practice | Oncology Videos ·

2026/09/22

Featuring perspectives from Dr David W Cescon, including the following topics: Clinical treatment of BRCA-mutated metastatic triple-negative breast cancer (0:00) CNS activity of TROP2-directed antibody-drug conjugates (5:36) Autoimmune considerations with immunotherapy (10:09) Treatment of oligoprogressive advanced breast cancer (17:31) CME information and select publications

en-us

29:44

Metastatic Triple-Negative Breast Cancer — 5-Minute...

Research To Practice | Oncology Videos ·

2026/09/21

Featuring perspectives from Dr David W Cescon, including the following topics: First-line treatment of metastatic triple-negative breast cancer (mTNBC) in patients not eligible for immunotherapy (0:00) First-line treatment of mTNBC in patients eligible for immunotherapy (12:05) Adverse events (19:39) CME information and select publications

en-us

622 results

Similar Podcasts

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

La Science CQFD

France Culture

Planetary Radio: Space Exploration, Astronomy and Science

The Planetary Society

aboutlogic

Deniz Sarikaya, Thorsten Altenkirch

The 365 Days of Astronomy

365DaysOfAstronomy.org